3
Announcements
Trials
Browse
Landscape
Status
Terminated
2
Unknown
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Breast
1
Conditions
Uveal Melanoma
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Hip Fractures
1
Fractures, Spontaneous
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
COVID-19
1
Breast Neoplasms
1
Ataxia Telangiectasia
1
Interventions
Paclitaxel
62
Letrozole
56
Fulvestrant
53
Trastuzumab
50
palbociclib
42
Carboplatin
38
pembrolizumab
37
Cyclophosphamide
37
Anastrozole
37
pertuzumab
35
exemestane
25
abemaciclib
24
Tamoxifen
24
Capecitabine
24
ribociclib
22
Radiotherapy
21
Docetaxel
21
olaparib
20
Doxorubicin
20
Magnetic Resonance Spectroscopy
18
trastuzumab deruxtecan
17
Surveys and Questionnaires
17
Epirubicin
17
durvalumab
16
Exercise
14
130-nm albumin-bound paclitaxel
14
Taxes
13
Specimen Handling
13
Alpelisib
13
Gonadotropin-Releasing Hormone
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Breast Neoplasms
×
Data Collection
×
Clear all
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled